Adelaide Research & Scholarship: Search

Search

Results 1-10 of 27 (Search time: 0.004 seconds).

previous
1
2
3
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2020	Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML	DiNardo, C.D.; Tiong, I.S.; Quaglieri, A.; MacRaild, S.; Loghavi, S.; Brown, F.C.; Thijssen, R.; Pomilio, G.; Ivey, A.; Salmon, J.; Glytsou, C.; Fleming, S.A.; Zhang, Q.; Ma, H.; Patel, K.P.; Kornblau, S.M.; Xu, Z.; Chua, C.C.; Chen, X.; Blombery, P.; et al.
	2019	Chromosomal abnormalities and prognosis in NPM1-mutated acute myeloid leukemia: a pooled analysis of individual patient data from nine international cohorts	Angenendt, L.; Röllig, C.; Montesinos, P.; Martínez-Cuadrón, D.; Barragan, E.; García, R.; Botella, C.; Martínez, P.; Ravandi, F.; Kadia, T.; Kantarjian, H.M.; Cortes, J.; Juliusson, G.; Lazarevic, V.; Höglund, M.; Lehmann, S.; Recher, C.; Pigneux, A.; Bertoli, S.; Dumas, P.Y.; et al.
	2019	Myocilin gene Gln368Ter variant penetrance and association with glaucoma in population-based and registry-based studies	Han, X.; Souzeau, E.; Ong, J.S.; An, J.; Siggs, O.M.; Burdon, K.P.; Best, S.; Goldberg, I.; Healey, P.R.; Graham, S.L.; Ruddle, J.B.; Mills, R.A.; Landers, J.; Galanopoulos, A.; White, A.J.R.; Casson, R.; Mackey, D.A.; Hewitt, A.W.; Gharahkhani, P.; Craig, J.E.; et al.
	2019	Heterozygous loss of function of IQSEC2/Iqsec2 leads to increased activated Arf6 and severe neurocognitive seizure phenotype in females	Jackson, M.R.; Loring, K.E.; Homan, C.C.; Thai, H.N.; Määttänen, L.; Arvio, M.; Jarvela, I.; Shaw, M.; Gardner, A.; Gecz, J.; Shoubridge, C.
	2021	Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia	Ochi, Y.; Yoshida, K.; Huang, Y.-J.; Kuo, M.-C.; Nannya, Y.; Sasaki, K.; Mitani, K.; Hosoya, N.; Hiramoto, N.; Ishikawa, T.; Branford, S.; Shanmuganathan, N.; Ohyashiki, K.; Takahashi, N.; Takaku, T.; Tsuchiya, S.; Kanemura, N.; Nakamura, N.; Ueda, Y.; Yoshihara, S.; et al.
	2014	The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17	Sommeijer, D.; Karapetis, C.; Zalcberg, J.; Tu, D.; Jonker, D.; Simes, J.; Tebbutt, N.; Yip, D.; Price, T.; O'Callaghan, C.
	2009	Screening for microsatellite instability identifies frequent 3'-untranslated region mutation of the RB1-inducible coiled-coil 1 gene in colon tumors	Paun, B.; Cheng, Y.; Leggett, B.; Young, J.; Meltzer, S.; Mori, Y.; Tan, P.
	2008	Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype	English, D.; Young, J.; Simpson, J.; Jenkins, M.; Southey, M.; Walsh, M.; Buchanan, D.; Barker, M.; Haydon, A.; Royce, S.; Roberts, A.; Parry, S.; Hopper, J.; Jass, J.; Giles, G.
	2014	Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)	Falchook, G.; Long, G.; Kurzrock, R.; Kim, K.; Arkenau, H.; Brown, M.; Hamid, O.; Infante, J.; Millward, M.; Pavlick, A.; Chin, M.; O'Day, S.; Blackman, S.; Curtis, C.; Lebowitz, P.; Ma, B.; Ouellet, D.; Kefford, R.
	2008	Association of PARL rs3732581 genetic variant with insulin levels, metabolic syndrome and coronary artery disease	Powell, B.; Wiltshire, S.; Arscott, G.; McCaskie, P.; Hung, J.; McQuillan, B.; Thompson, P.; Carter, K.; Palmer, L.; Beilby, J.